SCHEMBL8207362

SCHEMBL8207362

Cc1cnc(N2CC[CH]CC2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.43
GPR119 Q8TDV5 2/20 0.43
HTR3A P46098 3/20 0.36
HRH4 Q9H3N8 1/20 0.36
SLC6A9 P48067 5/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CNR2 P34972 3/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629285 0.83 KCNH2 (0.45) KCNH2GPR119ALDH1A1MAPTSMN1; SMN2
SCHEMBL240638 0.81 SMN1; SMN2 (0.47) KCNH2GPR119ALDH1A1MAPTSMN1; SMN2
SCHEMBL81828 0.79 HTR3A (0.52) KCNH2GPR119HTR3AHRH4RAB9A
SCHEMBL19145233 0.79 SLC6A9 (0.44) KCNH2GPR119SLC6A9ALDH1A1KDM4E
SCHEMBL807298 0.78 ALDH1A1 (0.54) HRH4ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL2629281 0.78 PLD1 (0.47) KCNH2GPR119HRH4ALDH1A1HPGD
SCHEMBL26340620 0.78 KCNH2 (0.42) KCNH2GPR119HTR3AHRH4SLC6A9
SCHEMBL2000301 0.76 GRIN2D (0.53) GPR119ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL1713165 0.76 HRH4 (0.41) HTR3AHRH4ALDH1A1MAPTSMN1; SMN2
SCHEMBL20180620 0.76 KCNH2 (0.41) KCNH2GPR119CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6110939-A AS A SUBSTANCE P ANTAGONISTS TREATING TACHYKININ-MEDIATED DISEASE, ASTHMA, CENTRAL NERVOUS SYSTEM DISORDER JANSSEN PHARMACEUTICA N.V. (BE) 2000-08-29 US disclosed